Cardiopulmonary exercise testing in transthyretin amyloid cardiomyopathy patients: a long-term follow-up study.
Robin WillixhoferRené RettlChristina KronbergerNikita ErmolaevBernhard GregshammerFranz DucaChristina BinderAndreas KammerlanderFarideh AlastiJohannes KastnerDiana BondermanJutta Bergler-KleinPiergiuseppe AgostoniRoza Badr EslamPublished in: Journal of cardiovascular medicine (Hagerstown, Md.) (2024)
ATTR-CM patients showed an improvement and deterioration in the short-term and long-term follow-up, respectively, with a better prognosis for those with peak VO 2 above 14 ml/kg·min and for a VE/VCO 2 slope below 40.